Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 53 % of short-term debt in 2024; threshold 65 %.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2024
AVISTER-MEDICAL from Verviers, company number BE0669862895, closed financial year 2024 with a result of € -99,722 after tax. For that financial year AVISTER-MEDICAL recorded a gross margin of € 28,326 and equity of € 58,820. Compared with financial year 2023, the result moved from € -58,657 to € -99,722. The company made a loss. The buffer shrank hard: equity is 69 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 3, 2025.
€ 58,820
▼ 69% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -99,722
▼ 70 % more loss than in 2023
Profit after tax over the fiscal year.
€ 56
▼ 92% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -296,530.
People and assets in 2024
€ 49,159
▼ 26% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 93,780
▲ 42% vs 2023
€ 30,286 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 118,228
▲ 4% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 16,745
▼ 38% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 28,477 | € 114,405 | € 28,326 | ▼ 75% |
| Profit after taxes | € -84,515 | € -58,657 | € -99,722 | ▼ € 41,065 |
| Equity | € 298,540 | € 189,157 | € 58,820 | ▼ 69% |
| Total debts | € 354,211 | € 334,454 | € 331,726 | ▼ 1% |
| Cash | € 22,338 | € 674 | € 56 | ▼ 92% |
| Retained profit | € -138,151 | € -196,808 | € -296,530 | ▼ € 99,722 |
| Bank debt | € 50,685 | € 65,877 | € 93,780 | ▲ 42% |
| Balance sheet total | € 652,751 | € 523,611 | € 390,546 | ▼ 25% |
Key figures of AVISTER-MEDICAL, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 January 2026.
What happened to AVISTER-MEDICAL?
What happened at AVISTER-MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
AVISTER-MEDICAL is active according to the CBE. Legal situation: Opening faillissement.
- NOSHAQ PARTNERS stepped down as director. NBB
- CLERM SRL stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 99,722. Source: NBB ↗
- NOSHAQ PARTNERS became a director. NBB
- CLERM SRL became a director. NBB
- Marwan ABBOUD stepped down as director. NBB
- Marwan ABBOUD became a director. NBB
- New establishment in Verviers. KBO
In short
From € 84,515 loss in 2022 to € 99,722 loss in 2024.
Paid € 523 in corporate taxes since 2022.
A new publication or filing at AVISTER-MEDICAL? We notify you, reason included.
Follow AVISTER-MEDICALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NOSHAQ EUROPE 3 comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
AVISTER-MEDICALThe shares are held by NOSHAQ EUROPE 3 (42.8%).
Directors
According to the 2024 annual accounts
Director · represented by Laurence Rosa
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +169 more
since 2024 · until 2030
Managing director · represented by Dauvister MARC
since 2024 · until 2030
since 2019 · until 2024
Shareholders
42.8%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue des Déportés 7 box A
4800 Verviers
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
OVH, FR
Domain
Domain
avister-medical.com
Registered
2016-12-11
Registrar
EuroDNS S.A.
Expires
2026-12-11
Website info
Features
Security
Details
- Company number
- 0669.862.895
- VAT number
- BE 0669.862.895
- Registered office
- Rue des Déportés 7 bus A, 4800 Verviers
- Names & denominations
- AVISTER-MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 23 January 2017
- Peppol
- Not registered
- Contact
- avister-medical.com
- Activities · NACE
Detailhandel in farmaceutische producten
Overige niet-gespecialiseerde detailhandel
Overige detailhandel in nieuwe artikelen neg
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Detailhandel via postorderbedrijven of via internet